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An improved in vitro expression system called the rapid translation system (RTS) was used in this 
study for the in vitro biosynthesis of 6x His tagged granulocyte colony stimulating factor (6x His-tagged 
granulocyte colony-stimulating factor (GCSF)). This was done to overcome the problems associated 
with traditional cell based biotechnology. The study involved the preparation of template DNA for cell-
free protein synthesis through gene amplification of open reading frame (ORF) of hGCSFb, cloning in 
pIVEX 2.4d vector and transformation of the produced construct in chemically competent Escherichia 
coli DH 5 α cells. A cell free protein synthesis system, RTS 100 E. coli HY kit, was tested for 6x His 
tagged G-CSF protein synthesis. Protein purification was done using Ni-NTA chromatography. Protein 
production was detected by two methods electrophoretically by sodium dodecyl sulfate polyacrylamide 
gel electrophoresis (SDS-PAGE) and immunologically by dot blotting immunodetection. The use of 
these methods yielded purified 6xHis-tagged GCSF with a concentration of about 250 µg/ml RTS 
reaction. 
 





Despite all its usefulness as a method for protein produc-
tion, recombinant DNA technology has a lot of problems 
such as insoluble inclusion body formation, instability of 
recombinant proteins due to the presence of intracellular 
proteases and the toxicity of some recombinant proteins 
to host cells. A cell free protein synthesis system can 
overcome these problems because it is essentially free of 
cellular control mechanisms to ensure its survival (Kim 
and Choi, 1996). The Escherichia coli extract, rabbit 
reticulocyte lysate and the wheat germ extract are the 
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synthesis. In the bacterial systems, the DNA species  are 
added to the translation mixture, and the corresponding 
mRNA would be synthesized in situ by the endogenous 
RNA polymerase present in the bacterial extract or its 
supernatant fraction (Spirin, 2003). Significant progress 
has being made using a bacterial cell-free transcription-
translation system from pure, individual components. 
These included recombinant His6-tagged translation 
factors (10 proteins), aminoacyl-tRNA synthetases (20 
proteins), methionyl-tRNA transformylase, T7 RNA poly-
merase and the proteins of an ATP regenerating sub-
system. In this system, bacterial ribosomes in the presence 
of appropriate plasmids produced correctly folded active 
proteins at a rate of about 0.1 mg/ml per hour (Shimizu et 
al., 2001). The invention of the continuous flow cell-free 
translation and coupled transcription-translation systems 
was a breakthrough as they overcame the main short-
coming of most test-tube translation and transcription-
translation systems which was their limited lifetime and 
as a consequence, their low yield of proteins (Spirin et 
al., 1988).                              





from multipotent stem cells of the bone marrow. The 
proliferation and differentiation of the progenitor cells for 
the granulocyte-macrophage lineage are regulated by a 
family of glycoproteins. These molecules are generally 
called colony-stimulating factors (CSFs) on the basis of 
morphology of the colonies stimulated. Granulocyte 
colony-stimulating factor (G-CSF) is almost specific for 
granulocytic lineage (Metcalf, 1985 and Nomura et al., 
1986). G-CSF thus plays a critical role in the process of 
hematopoiesis, regulating the proliferation, differentiation 
and survival of neutrophils and neutrophilic progenitor 
cells (Bishop et al., 2001). Mouse granulocyte colony-
stimulating factor (GM-CSF) was first recognized and 
purified in Australia in 1983 (Metcalf, 1985), and the 
human form was cloned by groups from Japan, Germany 
and United States in 1986 (Nagata et al., 1986 and 
Souza et al., 1986). G-CSF and GM-CSF are integral 
parts of the prevention of potentially life-threatening febrile 
neutropenia; however, only G-CSF has US FDA approval 
for use in chemotherapy-induced neutropenia. GCSF 
accelerate formation of neutrophils from committed 
progenitors and apart from granulopoiesis stimulation can 
also increase phagocytic and oxidative capacity of granu-
locytes after chemotherapy, thereby reducing the duration 
and severity of neutropenia (Dale, 2002). In addition, it is 
also used as support following autologous and allogenic 
bone marrow transplantation, and collection of CSF-
mobilized peripheral blood progenitor cells (DiPersio and 
Pusic, 2008). G-CSF was reported to induce myocardial 
regeneration by promoting mobilization of bone marrow 
stem cells to the injured heart after myocardial infarction. 
G-CSF also reduced apoptosis of endothelial cells and 
increased vascularization in the infarcted hearts, further 
protecting against ischemic injury (Harada et al., 2005). 
The aim of the present work is the use of rapid transla-
tion system (RTS), introduced by Roche applied science, 
which  is a cell-free protein production system employing 
an enhanced E. coli lysate to perform coupled in vitro 
transcription-translation reactions for the production of 6x 
His tagged GCSF. 
 
 
MATERIALS AND METHODS 
 
Gene amplification of open reading frame (ORF) of hGCSFb 
 
E. coli bacteria, strain GT 110 transformed by pORF 9-hGCSFb (an 
expression vector containing the human G-CSFb open reading 
frame) was obtained from Invivogen, France. The extraction of 
pORF9-hGCSFb was performed using a QIAprep Miniprep kit 
Qiagen, Hilden, Germany. The restriction digestion of the purified 
plasmid was done using Hind III restriction enzyme according to the 
manufacturer, Fermentas EU. This was followed by electrophoresis 
in 0.7% agarose gel / TAE at 70 volt and 90 mA (Sambrook and 
Russell, 2001).  The DNA extraction from agarose gel was perfor-
med using a QIAquick gel extraction kit Qiagen, Hilden, Germany. 
 
 
Polymerase chain reaction (PCR) reaction 
 
Primers’ design was performed using  the  fast  PCR  free  software  







Forward primer I 
 
 5’→3’ CAGTGCA CA↓TATGACAGTGCAGGAAGCCACC 





 5’ → 3’ TCATGTCGAGCCC↓GGGTTCTGCTC 
The underlined represents SmaI restriction site 
 
 
Forward primer II 
 
 5’ → 3’ CAGTGCACA↓TATGACAATCGAGGGACGC↓ACC 
The underlined represents NdeI restriction site, while the bold 
represents factor Xa protease cleavage site. 
 
 
First PCR reaction mixture 
 
0.5 µl pure Hind III digest (1.8 µg/µl), 10x PCR buffer , 2.5 mM 
dNTPs(Sigma Inc., St Louis ,Mo, USA),Forward Primer I (100 
pmole/ µl) (Qiagen, Operon), Reverse Primer (100 pmole/ µl), Q 
factor (5x), Taq polymerase enzyme( Qiagen Hilden, Germany) 2.5 
units in a final volume of 50 µl. PCR was performed in a Techne 
Touchgene Gradient thermal cycler, USA .The cycling conditions 
used were one cycle of 95°C for 5 min, 35 cycles each of 95°C for 
45 sec, 58°C for 45 sec (chosen from a gradient of annealing 
temperatures) and  72°C for 1 min and ending with a final extension 
at 72°C for 8 min. Samples were held at 4°C prior to analysis. The 
reaction mixture was analysed by gel electrophoresis through 0.7% 
(w/v) agarose in 1 x TAE buffer. The optimum PCR reaction was 
purified using QIAquick gel extraction kit. 
 
 
The second PCR reaction 
 
The purified 1st PCR product was used as template in the second 
reaction. Optimization of the second PCR reaction was carried out 
by changing annealing temperature, concentration of primers and 
addition of certain additives. The PCR reaction consist of 1 µl pure 
first PCR product, 10x PCR buffer , 2.5 mM dNTPs (Sigma Inc., St 
Louis ,Mo, USA), Forward Primer II (10 pmole/ µl) (Qiagen, Operon), 
Reverse Primer (10 pmole/ µl), 25 mM Mgcl2, Q factor (5x),Taq 
polymerase enzyme (Qiagen Hilden, Germany) 2.5 units in a final 
volume of 50 µl. PCR was performed in a Techne Touchgene 
Gradient thermal cycler, USA .The cycling conditions used were 
one cycle of 95°C for 5 min, 35 cycles each of 95°C for 45 sec, 
55°C  for 45 sec and  72°C for 1 min and ending with a final exten-
sion at 72°C for 8 min. Samples were held at 4°C prior to analysis. 
Each reaction mixture was analysed by gel electrophoresis through 
0.7% (w/v) agarose in 1x TAE buffer. The second PCR reaction 
product was purified using QIAquick gel extraction kit and was 
further purified by phenol: chloroform: isoamyl alcohol (25:24:1) at 
pH 8 (Sigma Inc., St Louis, Mo, USA) according to the method of 
Sambrook and Russell (2001). 
 
 
Cloning in pIVEX 2.4d vector (Roche Diagnostics, Germany) 
and transformation of the produced construct in chemically 
competent E. coli DH 5 α cells 
 
SmaI/NdeI (Roche Diagnostics., Germany) was used for the 
digestion   of   the   second  PCR  product  and  pIVEX  2.4d  vector  




according to the manufacturer. The digested pIVEX 2.4d vector was 
further dephosphorylated using shrimp alkaline phosphatase (Roche 
diagnostics., Germany). The digested dephosphorylated vector and 
digested PCR product was purified using QIAquick gel extraction kit  
then further purified by phenol : chloroform : isoamyl alcohol 
(25:24:1) pH 8 (Sambrook and Russell, 2001).  
 
 
Preparation of the ligation reactions 
 
Molar ratios (1:5, 1:7, 1:10) of digested vector and insert were 
checked, 3 units T4 DNA Ligase and 30% PEG 8000 were used. 
The reactions were incubated overnight at 16°C (Sambrook and 
Russell, 2001).Chemically competent cells of E. coli DH 5 α were 
prepared and transformed according to the method of Pharmacia 
U.S.E mutagenesis manual. Testing the efficiency of transformation 
was done by using intact pIVEX 2.4d vector.  
 
 
Preparation of minipreps from clones suspected to contain the 
pIVEX 2.4d-second PCR construct using QIAprep miniprep kit 
 
The procedure was carried out according to the manufacturer and 
optimization of the protocol was carried out by testing incubation 
temperature of 30°C and addition of chloramphenicol.  
 
 
A cell free protein synthesis system, RTS 100 E. coli HY kit 
(Roche Diagnostics., Germany), was tested for 6x His tagged 
G-CSF protein synthesis  
 
The reaction solution was prepared according to the manufacturer 
and incubated at 30°C for 20 h. The reaction solution was stored 
frozen until purification or further processing. 
 
 
SDS-polyacrylamide gel electrophoresis (SDS-PAGE) for the 
RTS 100 E. coli HY reaction 
 
Electrophoresis in 15% polyacrylamide gels was performed 
according to the method of Laemmli (1970). A BioRad mini-protein 
dual slap cell was used for running electrophoresis. The RTS 
samples were precipitated with acetone prior to the addition of 
SDS-PAGE sample buffer. The pellet was then dissolved in 70 µl 1x 
SDS-PAGE sample buffer and heated for 5 min at 95°C. Samples 
were cooled before applying 25 µl to gels. Electrophoresis was 
carried out at 90 volts and 40 mA for 90 min. Gels were stained for 
30 min with 0.1% (w/v) coomassie blue R-250 in fixative whose 
composition is: 20% (v/v) methanol and 10% (v/v) glacial acetic acid 
and destained in 14.2% (v/v) methanol and 10% (v/v) glacial acetic 
acid overnight.  
 
 
Protein purification was done using Ni-NTA chromatography 
(Qiagen Hilden, Germany) 
 
Protein purification using Ni-NTA spin columns was carried out, 
according to the manufacturer. The eluted protein was precipitated 
with acetone prior to the addition of the SDS-PAGE sample buffer 
this was followed by SDS PAGE.  
 
 
Determination of Ni-NTA spin column purified protein content  
 
Protein purified from Ni–NTA spin kit was precipitated with acetone 
then resuspended in 10 µl distilled H2O. Protein content deter-
mination was carried out by coomassie blue dye assay according to 





Dot blotting immunodetection of 6xHis-tagged proteins with 
anti-His HRP conjugates (Chromogenic method) (Qiagen 
Hilden, Germany) 
 
The RTS samples were precipitated with acetone prior to the 
addition of the denaturating buffer. The produced pellet was then 
dissolved in 200 µl denaturating buffer, 10 µl of the diluted protein 
sample was applied directly onto a nitrocellulose membrane. After 
applying the samples, the membrane was air dried at room tempe-
rature before proceeding with the detection process according to 









The first PCR reaction 
 
Hind III digested pORF9-hGCSFb was used as a 
substrate. Gradient of annealing temperatures ranging 
from 58 → 69°C for 45 sec was tested. At the end of the 
PCR reactions, the different reactions performed using 
different annealing temperatures were screened using 
DNA agarose gel electrophoresis. The results of the first 
PCR reaction are shown in Figure 1. Annealing tempe-
ratures 58, 59.4 and 60.4°C showed high intensity bands 
of first PCR product of size 626 bp, annealing tempe-
ratures 61.5, 62.5°, 63.5 and 64.3°C showed lower 
intensity bands of first PCR product. Thus, it can be 
concluded that the best annealing temperature for the 
first PCR reaction is 58°C. 
 
 
The second PCR reaction 
 
First PCR reaction product was used as a substrate. 
Gradient of annealing temperatures ranging from 58 → 
69°C for 45 sec were tested. No distinct bands of the 
second PCR product of size 626 bp were observed on 
agarose gel. The first PCR reaction product was used as 
a substrate. Another gradient of annealing temperatures 
ranging from 52 → 58°C was tested. The results of the 
second PCR reaction are shown in Figure 2 where 
annealing temperatures ranging from 53.7 to 56.2°C 
showed intense bands of second PCR product of size 




Optimization of the second PCR reaction 
 
Attempts to optimize the second PCR reaction were done 
by testing different variables including the testing of two 
different annealing temperatures, 54 and 55°C; the use of 
two different primers' concentration of 100 and 10 
pmole/µl, supplementing the reaction with 25 mM Mgcl2 







Figure 1. Agarose gel of first PCR reaction using 
gradient annealing temperatures from 58 to 64.3°C. Lane 
1,  DNA molecular weight marker XVII, Roche 
diagnostics., Germany,  (500 base pair ladder from 5000  
– 500 bp); Lane 2, PCR reaction with annealing 
temperature 58°C; Lane 3, PCR reaction with annealing 
temperature 59.4°C; Lane 4, PCR reaction with 
annealing temperature 60.4°C;  Lane 5, PCR reaction 
with annealing temperature 61.5°C; Lane 6, PCR 
reaction with annealing temperature 62.5°C; Lane 7, 
PCR reaction with annealing temperature 63.5°C; Lane 




and Q factor. At the end of the PCR run, the 16 different 
reactions performed using these variables were screened 
using DNA agarose gel electrophoresis and the results 
are shown in Figures 3 and 4. The intensity of second 
PCR product band corresponding to each optimized 
second PCR reaction is recorded in Table 1.  
The diluted primers reactions (I, K, M, O, J, L, P and N) 
gave better results than concentrated primers reactions 
(A, C, E, G, B, D, F and H). The sharpest intense band of 
the second PCR product was obtained when using an 
annealing temperature of 55°C, primers’ concentration of 
10 pmole/µl and supplementing the reaction with 25 mM 
Mgcl2 and Q factor. 
 
 
Cloning in pIVEX 2.4d vector and transformation of 
the produced construct in chemically competent E. 
coli DH 5 α cells 
 
Transformation of chemically competent E. coli DH 5 
α cells 
 
Examination of ampicillin Lysogeny broth (LB) agar plates 
inoculated with the three different transformation ligation 
reactions revealed that the ligation reaction with the high-
est vector to insert molar ratio (1:10) produced the largest 
number of colonies. One of these colonies  contained  the  






Figure 2. Agarose gel of second PCR reaction using gradient 
annealing temperatures from 52 to 58°C. Lane 1, DNA molecular 
weight marker XVII (500 base pair ladder ranging from 5000 bp – 
500 bp); Lane 2, first PCR product; Lane 3, PCR reaction with 
annealing temperature 52°C; Lane 4, PCR reaction with annealing 
temperature 52.9°C; Lane 5, PCR reaction with annealing 
temperature 53.7°C; Lane 6, PCR reaction with annealing 
temperature 54.6°C; Lane 7, PCR reaction with annealing 
temperature 55.2°C; Lane 8, PCR reaction with annealing 
temperature 56.2°C; Lane 9, PCR reaction with annealing 









Preparation of minipreps from clone suspected to 
contain pIVEX 2.4d-second PCR construct using 
QIAprep miniprep kit 
 
Using the original protocol for the preparation of mini-
preps followed by agarose gel electrophoresis revealed 
plasmid DNA of the right molecular weight of 4148 bp but 
contaminated with chromosomal DNA. This chromosomal 
DNA contamination appeared as a background smear in 
the prepared gel as shown in Figure 6. 
To overcome the contamination of the produced plas-
mid with chromosomal DNA, some modifications to the 
original protocol were done. These modifications include 
doubling the volume of the original  culture,  doubling  the  






Figure 3. Agarose gel of optimized second PCR reactions 
using annealing temperature of 54°C. Lane 1, DNA molecular 
weight marker XVII (500 base pair ladder ranging from 5000 
bp – 500 bp); Lane 2, First PCR product; Lane 3, Reaction A; 
Lane 4, Reaction I; Lane 5, Reaction C; Lane 6, Reaction; 
Lane 7, Reaction E; Lane 8, Reaction M; Lane 9, Reaction G; 




concentration of ampicillin added to be 200 µg /ml, 
decreasing the incubation temperature to 30°C and the 
incubation time to 12 h without shaking and doubling the 
volumes of reconstitution, lysis and neutralization buffers. 
These modifications produced pure plasmid of molecular 
weight of 4148 bp, but with low yield. Concentration of 
the produced plasmid was performed by combining the 
yield of 2 miniprep reactions together and this was further 
purified and concentrated by mixing 100 µl prepared 
plasmid with 500 µl binding buffer and applying the 
produced mixture on a new column. This resulted in 
plasmid of high intensity and purity with molecular weight 
of 4148 bp.   Adding chloramphenicol to a final concen-
tration of 25 µg/ml to the starter culture together with the 
previously mentioned modifications resulted in plasmid 
with the highest intensity and purity and of molecular 
weight of 4148 bp as shown in Figure 7. 
 
 
A cell free protein synthesis system, RTS 100 E. coli 
HY kit, was tested for 6x His tagged G-CSF protein 
 
SDS-polyacrylamide gel electrophoresis for the RTS 
100 E. coli HY reaction 
 
Electrophoresis in 15% polyacrylamide gels was 
performed. A band corresponding to the 6xHis-tagged 
GCSF with a molecular weight of 21,978 kDa was 
produced as shown in Figure 8. The 6xHis- tagged GCSF 







Figure 4. Agarose gel of optimized second PCR reaction 
using annealing temperature of 55°C. Lane 1, DNA molecular 
weight marker XVII (500 base pair ladder ranging from 5000 – 
500 bp); Lane 2, First PCR product; Lane 3, reaction B; Lane 
4, reaction C; Lane 5, reaction D; Lane 6, reaction L; Lane 7, 









SDS-PAGE for the Ni-NTA purified 6xHis- tagged 
GCSF protein 
 
Ni-NTA metal affinity chromatography matrices (Ni-NTA 
Spin columns) were used for the purification and 
extraction of the 6xHis- tagged GCSF from RTS 100 E. 
coli HY reaction. Electrophoresis in 15% polyacrylamide 
gels was performed. A band corresponding to 6xHis- tag-
ged GCSF with a molecular weight of 21,978 kDa was 
observed as shown in Figure 9. 
 
 
Ni-NTA spin column purified 6xHis-tagged GCSF 
protein content 
 
Protein purified from a single Ni –NTA Spin column 
reaction, corresponding to one 50 µl RTS reaction was 
used for determination of protein content. The 6xHis- tag-
ged GCSF produced from a 50 µl RTS reaction is equal 
to 12.7 µg, approximately 250 µg/ml RTS reaction. 
 
 
Dot blotting immunodetection of 6xHis-tagged 
proteins with anti-His HRP conjugates (Chromogenic 
method) 
 
Anti.His HRP conjugate was used for direct detection of 
6xHis-tagged GCSF protein by  chromogenic  method.  A  









Intenisty  of  second 










Ta 54ºC Ta 55ºC 
A •     • •   + 
B •     •  •  + 
C •   •   • •   ++ 
D •   •   •  •  +++ 
E •    •  •   ++ 
F •    •   •  ++ 
G •   •  •  •   +++ 
H •   •  •   •  ++ 
I  •    • •   +++ 
J  •      •  + 
K  •  •    •   +++ 
L  •  •   •  •  ++++ 
M  •   •  •   +++ 
N  •   •   •  + 
O  •  •  •  •   +++ 
P  •  •  •   •  + 
 






Figure 5. Comparison between pIVEX 2.4d vector 
and plasmid extracted from a colony of transformed 
cells with the vector to insert molar ratio (1:10) 
prepared by toothpick minipreparation method. Lane 
1, DNA molecular weight marker XVII (500 base pair 
ladder 5000 – 500 bp); Lane 2, pIVEX 2.4d vector of 
molecular weight of 3583 bp; Lane 3, plasmid from 




Figure 6. Agarose gel of miniprep of the 
transformant clone.  Lane 1, DNA molecular 
weight marker XVII (500 base pair ladder ranging 
from 5000 bp – 500 bp); Lane 2, pIVEX 2.4d 




coloured precipitate was observed on the nitrocellulose 
strip at the site of application of the sample as shown in 
Figure 10. This confirmed the production of the protein of 
interest, 6xHis- tagged GCSF protein by RTS 100 E. coli  






Figure 7. Comparison between diluted and 
concentrated extract of pIVEX 2.4d-second PCR 
construct miniprep with that extracted after the 
addition of chloramphenicol. Lane 1,  Gene Ruler 
TM 
1 Kb DNA ladder (showing 14 bands 10000, 8000, 
6000, 5000, 4000, 3500, 3000, 2500, 2000, 1500, 
1000, 750, 500 and 250 bp); Lane 2, Miniprep of 
transformed clone prepared by the addition of 
chloramphenicol to the starter culture; Lane 3,   
Miniprep of transformed clone prepared with the 
modified extraction protocol; Lane 4,  concentrated 









Recombinant G-CSF has wide pharmaceutical applica-
bility. In this study, we explored the expression of recom-
binant G-CSF in rapid translation system. RTS was 
invented and manufactured by Roche company. It is one 
of the simplest systems to express target proteins in vitro 
to overcome the problems associated with traditional 
protein production using recombinant DNA technology 
(Zhou et al., 2003)  This study involved preparation of 
template DNA for cell free protein synthesis, protein 
expression in RTS 100 E. coli HY kit and protein 
purification. Confirmation of G-CSF production by RTS 






1  2    3  
 
 
Figure 8. SDS-PAGE for the RTS 100 E. coli 
HY reaction. Lane 1-2, PAGE Ruler
TM 
unstained protein ladder showing 14 bands 
200, 150, 120, 100, 85, 70, 60, 50, 40, 30, 
25, 20, 15 and 10 kDa, respectively; Lane 3, 





Template DNA for cell-free protein synthesis gene 
amplification by PCR hGCSFb gene primers’ design 
 
Many plasmid vectors carry promoters derived from 
bacteriophages such as T3, T7 and SP6 adjacent to the 
multiple cloning site (MCS). Foreign DNA inserted at 
restriction sites within MCS can be transcribed in vitro 
when the recombinant plasmid is incubated with the 
appropriate DNA-dependent RNA polymerase (Sambrook 
and Russell, 2001). Some vectors carry two bacte-
riophage promoters in opposite orientations, located on 
each side of the MCS. This organization allows RNA to 
be synthesized in vitro from either end depending on the 
type of RNA polymerase used (Short et al.,1988). Vectors 
carrying the T7 promoter can be used to express cloned 
DNA sequences in bacteria or in vitro systems containing 
T7 RNA polymerase (Tabor and Richardson,1985).The 
target gene in the vector to be used in RTS system 
should be under the control of a T7 promoter located 
downstream of a ribosomal binding site (RBS) sequence, 





     4           3      2    1     
 
 
Figure 9. SDS-PAGE for Ni-NTA purified 6xHis- 
tagged GCSF protein. Lane 1-2, PAGE Ruler
TM 
Unstained protein ladder showing 14 bands 200, 
150, 120, 100, 85, 70 , 60, 50, 40, 30, 25, 20 ,15 
and 10 kDa, respectively; Lane 3, RTS reaction 
showing the protein of interest 6x His-tagged GCSF; 





should not exceed 100 base pairs, the distance between 
the RBS sequence and start codon (ATG) should not be 
more than 5–8 base pairs, T7 terminator sequence 
should be present at the 3’ end of the gene as 
recommended by the manufacturer of the RTS 100 E.coli 
HY kit.  
In this study, pIVEX 2.4d vector contained all the 
regulatory elements necessary for in vitro expression 
including a T7 promoter (T7-P), a ribosomal binding site, 
a start codon (ATG) upstream of a multiple cloning site 
for the insertion of the target gene together with a stop 
codon and a T7 terminator (T7-T). In addition the 
pIVEX2.4d vector also contained a region coding for His6 
tag and  a  factor  Xa  protease  cleavage  site  sequence 






Figure 10. Dot blotting immunodetection 
of 6x His-tagged proteins with anti-His 





upstream of the multiple cloning site to allow for the 
purification of expressed proteins via Ni-NTA matrices 
(http://www. rocheappliedscience.com/sis/ protein 
expression/literature/vector_pivex2.4d.htm). The portion 
coding for the protein, GCSF, was intended to be cloned 
in pIVEX2.4d vector satisfying the requirements pre-
viously discussed. 
Taking into consideration that the RTS system cannot 
introduce post-translation modification as signal sequen-
ce cleavage, in order to produce a protein with no 
additional bases at the N- terminus a protease cleavage 
site, factor Xa protease, was introduced directly in the 
forward primer upstream of the target gene sequence. 
Proteases that have been commonly employed to cleave 
fusion tags include tobacco etch virus (TEV) protease 
(Carrington et al., 1989 and Rocco et al., 2008), factor Xa 
(Smith and Johnson, 1988 and Jenny et al., 2003) and 
enterokinase (LaVallie et al., 1993; Lasnik et al., 2001). 
Factor Xa was chosen in this study as there was no 
factor Xa restriction site within the protein sequence .This 
promoted the production of intact pure protein. The 
sequence encoding the signal peptide of hGCSFb started 
at position 570, the sequence encoding the mature 
peptide started at position 661, while the sequence 
encoding the stop codon was at position 1184 of pORF9-
hGCSFb.            
According to our cloning strategy, a restriction enzyme 
NdeI sequence was introduced in the forward primer and 
a restriction enzyme SmaI sequence was introduced in 
the reverse primer. A NdeI restriction site sequence 
together with a factor Xa protease cleavage site sequen-
ce introduced in the forward primer in one step means 
the introduction of 12 proper base substitution mutations. 
This will render the primer unstable and of low quality. So 
in order to correct for this difficulty, we introduced these 





Choosing the optimum annealing temperature requires 
repeating PCR reactions with a different temperature 
each time which increases the cost and waste time. 
Thus, we performed a series of PCR reactions with a gra-
dient of annealing temperatures in one run for both the 
first and second PCR reactions. 




Optimization of the second PCR reaction 
 
The primer and Mg
2+
 concentration in the PCR buffer and 
annealing temperature of the reaction may need to be 
optimized for each primer pair for efficient PCR (Ling et 
al., 1991 and Forbes et al., 1993). In addition, PCR 
efficiency can be improved by additives that promote 
DNA polymerase stability. Q-solution according to the 
manufacturer will often enable or improve suboptimal 
PCR systems caused by templates that have a high 
degree of secondary structure or that are GC-rich.  
Attempts to optimize the second PCR reaction were 
done by testing 16 different variables combinations, inclu-
ding the testing of two different annealing temperatures 
54 and 55°C, the use of two different primers' concen-
tration 100 and 10 pmole/µl, supplementing the reaction 
with 25 mM MgCl2 and testing 2 surfactants 5% DMSO 
and Q factor. It was shown that an annealing temperature 
of 55°C, using the primers’ concentration of 10 pmole/µl 
and supplementing the reaction with 25 mM Mgcl2 and Q 
factor produced sharp intense bands of the second PCR 
product. Thus, using diluted primers is shown to increase 
the specificity of the PCR reaction and supplementing the 
reaction with 25 mM Mgcl2 greatly improved the yield 
(sensitivity) of the second PCR reaction. This result is 
consistent with that stated in Roux (1995). 
 
 
Preparation of the pIVEX 2.4d vector-second PCR 
construct Restriction digestion of pIVEX 2.4d vector 
and second PCR product 
 
Restriction digestion was performed in this study for both 
the second PCR reaction product and the pIVEX2.4d 
vector. Improvement of the digestion reaction was done 
by increasing the incubation periods of the digestion 
reactions to 2½ h instead of 1½ h. Also, the inactivation 
of restriction enzymes at the end of the reaction by 
heating at 65°C for 15 min enhanced further processing 
of the digested products. This result was consistent with 
that reported in http://www.neb .com/nebecomm/ 
products/faqcategory1.asp#663. Restriction digestion 
with SmaI produced blunt ends while restriction digestion 
with NdeI produced sticky ends. 
In order to prevent religation of blunt ended linearized 
digested plasmid DNA, the digested vector was further 
dephosphorylated with shrimp alkaline phosphatase 
(SAP). SAP has advantage over calf intestinal phos-
phatase in that it is completely and irreversibly inactivated 
by heat treatment for 15 min at 65°C. SAP is active on 
either 5’-protruding or blunt ends. 
 
 
Preparation of the ligation reaction 
 
To achieve optimum results in ligation, different ratios of 
digested second PCR and digested pIVEX 2.4d vector 





instruction manual to use a molar ratio vector: insert of 
1:5 in case of blunt end ligation. The insert to vector 
molar ratio can have a significant effect on the outcome 
of a ligation and subsequent transformation step. Molar 
ratios can vary from a 1:1 insert to vector molar ratio to 
10:1. It may be necessary to try several ratios in parallel 
for best results (DNA ligation, http://openwetware.org/ 
wiki/DNA_ligation). In our study, it was observed that the 
molar ratio of vector: insert of 1:10 produced the desired 
ligated product. 
In order to increase the chance of blunt end ligation in 
this study, 15% w/v PEG 8000 was added to the ligation 
reaction. This result was consistent with that determined 
by Pheiffer and Zimmerman (1983); they found that the 
addition of  15% w/v PEG 8000 to ligation reactions 
increase the chances of blunt end ligation by more than 
95%. The addition of high concentrations of polyethylene 
glycol 8000 to the reaction mixture causes macro-
molecular crowding, which strongly enhances blunt- and 
cohesive-end ligations and prevents intramolecular 
circularization (Pheiffer and Zimmerman, 1983). 
 
 
Preparation of chemically competent cells 
 
Transformation of chemically competent E. coli DH5α 
cells 
 
By testing different ligation variables, it was found that 
ligation reaction with the highest vector: insert molar ratio 
(1:10) produced the largest number of colonies. 
Screening of all the obtained colonies, from the different 
tested ligation reactions, for the transformed plasmid 
revealed a clone containing a plasmid with the expected 
molecular weight of 4148 bp, In contrast to recom-
mendations by T4 DNA ligase instruction manual ligation 
reaction using 1:5 molar ratio of vector: insert, revealed 
no plasmid while 1:10 molar ratio of vector: insert 
produced the desired plasmid. 
 
 
Optimization of the QIAprep miniprep kit's protocol 
 
Using the original miniprep kit's protocol for extraction of 
plasmid pIVEX 2.4d vector-second PCR construct from 
E.coli DH5α cells, yielded plasmid DNA of the correct 
molecular weight of 4148 bp but contaminated with 
sheared chromosomal DNA. This represented a problem 
as the purity of the plasmid preparation is essential for in 
vitro protein synthesis. This problem was not simply 
solved by purifying DNA fragments from agarose gels, as 
this treatment inhibits in vitro protein synthesis as recom-
mended by the manufacturer of the RTS system. The 
prepared lysates in this study were too viscous to 
promote gentle handling. The increased viscosity of 
lysates caused genomic DNA shearing (Sambrook and 
Russell, 2001).  





original Qiagen protocol were tested. Culturing the single 
colony in double the amount of LB broth and doubling the 
volumes of reconstitution, lysis and neutralization buffers 
used were tested. These modifications reduced the 
viscosity of lysates and promoted gentle handling of lysates. 
The pIVEX 2.4d vector has an ampicillin resistant 
marker. Ampicillin is an unstable antibiotic and is rapidly 
depleted in growing cultures due in part to the β-lacta-
mase secreted by resistant bacterial cells. Daughter cells 
that do not receive plasmids will replicate much faster 
than plasmid containing cells and can quickly take over 
the culture. Doubling the concentration of ampicillin 
sodium salt to 200 µg/ml, in this study will maintain the 
transformant clones always under stress and prevent 
them from losing the plasmid (Qiagen plasmid resource-
center, http://www1. qiagen.com/Plasmid/Bacterial 
Cultures.aspx#tab2). 
In order to prepare fresh cultures with no lysed cells or 
degraded DNA, we reduced the incubation temperature 
to 30°C and the incubation time to 12 hours without 
shaking as overgrown cultures contain lysed cells and 
degraded DNA (Qiagen plasmid resource center, 
http://www1.qiagen.com/Plasmid/ BacterialCultures. 
aspx#tab2). 
 The previously mentioned modifications combined 
together gave rise to a plasmid with high purity and of the 
expected molecular weight of 4148 bp, but with low 
concentration. To further purify and concentrate the 
prepared minipreps, each 2 miniprep reactions were 
pooled together and were further purified and concen-
trated by mixing 100 µl prepared plasmid with 500 µl 
binding buffer and reapplying the produced mixture to a 
new column. This treatment yielded pure concentrated 
plasmid with the expected molecular weight of 4148 bp. 
Although the plasmid can be purified in large yield from 
bacterial cultures that are allowed to grow to saturation in 
the absence of chloromphenicol, the treatment with sub-
minimal concentration of chloromphenicol is beneficial. 
Chloromphenicol inhibits protein synthesis and blocks 
host DNA synthesis, but has no effect on the replication 
of plasmids. This reduced the bulk and viscosity of 
bacterial lysates, without affecting plasmid replication 
(Sambrook and Russell, 2001). Thus, in this study 
chloramphenicol was added to a final concentration of 25 
µg/ml in the overnight culture to reduce the viscosity of 
lysates. The addition of chloramphenicol yielded plasmid 
DNA of high purity, with the expected molecular weight of 
4148 bp and of high concentration. 
 
 
Protein expression in RTS 100 E. coli HY kit 
 
The RTS E. coli HY lysate used in this study contains all 
the machinery needed to drive coupled transcription and 
translation of a DNA template in a single reaction vessel. 
The RTS 100 E.coli HY kit was tested for protein 
synthesis using the purified pIVEX 2.4d–second PCR 
construct as template DNA. A band corresponding to  the  




protein of interest His6 tag-GCSF with a molecular weight 
of 21,978 kDa was visualized after coomassie blue 
staining of the polyacrylamide gel. Similar studies using 
RTS system for cloning and expression of the HIV protein 
in Escherichia coli cell-free system was reported by Chen 
et al. (2007). 
 
 
Protein purification using Ni-NTA spin column 
 
The vector pIVEX 2.4d contains a region coding for His6 
tag upstream of the multiple cloning site. A hexa-histidine 
tag was added to the N-terminus of the protein by cloning 
the gene coding GCSF in pIVEX2.4d vector. In order to 
achieve one step separation and exact processing, His6 
tag-GCSF purification from the RTS reaction was perfor-
med in this study by using Ni-NTA spin columns. Similar 
studies involving purification of His6 tagged proteins by 
Ni-NTA are discussed in Lasnik et al. (2001), Beeler et 
al.(2004 ), Jianbo et al.(2007) and  Bogomolovas et 
al.(2009). 
A band corresponding to the purified protein His6 tag-
GCSF with a molecular weight of 21,978 kDa was 
detected on the polyacrylamide gel after coomassie blue 
staining. This confirmed the production of His6 tag-GCSF 
by RTS 100 E.coli HY reaction. 
 
 
Ni-NTA spin column purified 6xHis- tagged GCSF 
protein content 
 
Determination of the His6 tag-GCSF protein content from 
a single Ni-NTA spin column purification reaction using 
coomassie blue dye assay according to the method of 
Bradford (1976) was done. The concentration of His6 tag-
GCSF produced from a 50 µl RTS reaction is equal to 
12.7 µg approximately 250 µg/ml RTS reaction. The 
protein yield from the traditional batch mode expression 
RTS 100 E. coli HY Kit approaches 400 µg/ml RTS 
reaction for the highly soluble and efficiently expressed 
proteins. The protein yield from a continuous exchange 
cell-free (CECF) reaction is up to 5 mg per ml using the 
RTS 9000 E. coli HY Kit. This is consistent with the fact 
that in the traditional batch mode expression, cell-free 
protein synthesis plateaus after approximately 2 to 4 h as 
substrates become exhausted and inhibitory reaction by-
products accumulate which accounts for the lower 
expression levels. In contrast, the RTS CECF format 
enables protein expression to continue for up to 24 h, 
maximizing protein yield. This is possible because the 
CECF system does not allow the build up of inhibitory 
products or the exhaustion of substrates (Spirin, 2003). 
 
 
Dot blotting immunodetection of His6 tagged 
proteins with anti-His HRP conjugate (chromogenic 
method) 
 
Protein detection using the dot blot protocol  is  similar  to  




western blotting in that both methods allow for the 
identification and analysis of proteins of interest. Dot blot 
methodology differs from traditional western blot techni-
ques by not separating protein samples using electro-
phoresis. Sample proteins are instead spotted onto mem-
branes and hybridized with an antibody probe. Semi-
quantitative measurements can be made for the spots. 
This is the fastest and simplest immobilization method 
where dilutions of the RTS reaction containing the His6 
tag-GCSF in denaturating buffer were pipetted directly on 
a nitrocellulose membrane. Anti-His HRP conjugate was 
used for simple, direct detection of His6 tag-GCSF. They 
comprise the tetra His antibody that recognizes the (His) 
4 epitope. Tetra His antibody binds to proteins that have 
His6 tag regardless of the surrounding amino-acid 
context. The anti-His HRP conjugate also contain a 
horseradish peroxidase (HRP) moiety that allows direct 
detection by chromogenic methods without the require-
ment of a secondary antibody (QIAexpress detection and 
assay handbook, 2002, third edition, Qiagen). Chromo-
genic substrates give rise to insoluble, colored products 
that form a precipitate on the nitrocellulose membrane 
consistent with the expected results in literature 
(QIAexpress detection and assay handbook, 2002, third 
edition, Qiagen). Similarly, dot blotting technique was 
used by Chapple et al. (2006) for screening of protein 
production in mammalian cells. This provided a further 
confirmation of the production of the protein of interest, 
His6 tag-GCSF protein, by RTS 100 E.coli HY kit.  
 
 
Future investigation suggestions 
 
(1) Further process optimization by protein expression in 
RTS 9000 E. coli HY Kit would most certainly further 
increase the yield to mg/ml range. 
(2) The optimization of the protein yield, the removal of 
the His6 tag  and further characterization of the produced 
protein will  quantitatively define the  process to a level 
which could be tested on a pilot scale and hence suites 
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